Skip to Content

93 7540 (Topiramate 50 mg)

Pill with imprint 93 7540 is Yellow, Capsule-shape and has been identified as Topiramate 50 mg. It is supplied by Teva Pharmaceuticals USA.

Topiramate is used in the treatment of epilepsy; lennox-gastaut syndrome; migraine prevention; seizure prevention; seizures and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Topiramate 50 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 93 7540

Topiramate 50 mg 93 7540
Topiramate 50 mg 93 7540
Topiramate 50 mg 93 7540

Topiramate

Imprint
93 7540
Strength
50 mg
Color
Yellow
Size
11.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Carbonic anhydrase inhibitor anticonvulsants
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA
National Drug Code (NDC)
00093-7540
Inactive Ingredients
silicon dioxide, lactose monohydrate, magnesium stearate, microcrystalline cellulose, polyethylene glycol 3350, corn starch, sodium starch glycolate type A potato, titanium dioxide, ferric oxide yellow, polyvinyl alcohol, magnesium silicate

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.